Assignee
COVIS PHARMA GMBH
CH·5 granted patents·2 pending applications·5 citations·filing 2019–2024
Top patents by PatentIndex Score
7 records- 0192US11304962B2Methods of reducing risk of preterm birthCOVIS PHARMA GMBH·Filed 2021·Granted Apr 19, 2022·2 cites·21 claims
- 0289US11154562B2Methods of reducing risk of preterm birthCOVIS PHARMA GMBH·Filed 2019·Granted Oct 26, 2021·3 cites·6 claims
- 0384US2024366592A1Anticoagulant reversal agentsCOVIS PHARMA GMBH·Filed 2023·Application pending·0 cites
- 0477US12370141B2Pharmaceutical aerosol product for administration by oral or nasal inhalationCOVIS PHARMA GMBH·Filed 2024·Granted Jul 29, 2025·0 cites·12 claims
- 0574US11730744B2Methods of reducing risk of preterm birthCOVIS PHARMA GMBH·Filed 2021·Granted Aug 22, 2023·0 cites·16 claims
- 0671US2021169874A1Anticoagulant reversal agentsCOVIS PHARMA GMBH·Filed 2020·Application pending·0 cites
- 0767US11992556B2Pharmaceutical aerosol product for administration by oral or nasal inhalationCOVIS PHARMA GMBH·Filed 2021·Granted May 28, 2024·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when COVIS PHARMA GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →